David B. Rosen

Rising Pharmaceuticals, Inc. engaged in selling niche pharmaceutical products. It offers Amiloride Hydrochloride tablets, Anastrozole tablets, Benazepril, Bethanechol, Carisoprodol, Cetirizine Hydrochloride, Cevimeline Hydrochloride, Chloroquine Phophate, and Ciprofloxacin Opthalmic Solutions. The company is headquartered in Saddle Brook, NJ.

Actylis Corp. engages in the development, marketing, sale, and distribution of chemical compounds used in the pharmaceutical, nutraceutical, agricultural, coatings, and industrial chemical industries. It operates through the following segments: Human Health, Pharmaceutical Ingredients, and Performance Chemicals. The Human Health segment develops and sells finished dosage form generic drugs and nutraceutical products. The Pharmaceutical Ingredients segment supplies active pharmaceutical ingredients and pharmaceutical intermediates. The Performance Chemicals segment comprises of specialty chemicals and agricultural protection products. The company was founded in 1947 and is headquartered in Port Washington, NY.

Part of NATCO Pharma Ltd., Dash Pharmaceuticals LLC is a front-end pharmaceutical sales, marketing and distribution company. The company is based in Upper Saddle River, NJ. The company was founded by Julie Trendowicz, Nick DiMaio, David B. Rosen. David B. Rosen has been the CEO since incorporation. Dash Pharmaceuticals was acquired by NATCO Pharma, Inc. on January 01, 2022 for $18 million.